Correlation Between Arcellx and Avalo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Arcellx and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcellx and Avalo Therapeutics, you can compare the effects of market volatilities on Arcellx and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Avalo Therapeutics.

Diversification Opportunities for Arcellx and Avalo Therapeutics

0.89

Correlation Coefficient

Arcellx  Avalo Therapeutics

Very poor diversification

The 3 months correlation between Arcellx and Avalo is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Arcellx i.e., Arcellx and Avalo Therapeutics go up and down completely randomly.

Pair Corralation between Arcellx and Avalo Therapeutics

Given the investment horizon of 90 days Arcellx is expected to generate 0.63 times more return on investment than Avalo Therapeutics. However, Arcellx is 1.58 times less risky than Avalo Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Avalo Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  8,759  in Arcellx on November 19, 2024 and sell it today you would lose (2,236) from holding Arcellx or give up 25.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Arcellx  vs.  Avalo Therapeutics

Arcellx

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Avalo Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Avalo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Arcellx and Avalo Therapeutics

The main advantage of trading using opposite Arcellx and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.

The idea behind Arcellx and Avalo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.